Breaking News

You are here » Indian-Commodity  :  Corporate  :  Zydus receives USFDA's nod for Dutasteride and Tamsulosin Hydrochloride Capsules

25-May2018

Zydus receives USFDA's nod for Dutasteride and Tamsulosin Hydrochloride Capsules

Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA) to market Dutasteride and Tamsulosin Hydrochloride Capsules, 0.5 mg/0.4 mg. The drug is used to treat symptoms of Benign Prostatic Hyperplasia (BPH). It will be manufactured at the group's manufacturing facility at Moraiya, Ahmedabad.

The group now has more than 190 approvals and has so far filed over 320 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies


Related News

View all news

Reliance Power's arm wins arbitration award against NACC

Reliance Power's Wholly Owned Subsidiary -- Sasan Power has won an arbitration award against North American Coal Corporation (NACC). This is a major milestone in this arbitration with the award received......

Tata Steel's arm signs agreement to divest entire stake in Black Ginger 461

Tata Steel's wholly owned indirect subsidiary -- TS Global Minerals Holdings Pte has entered into an agreement to divest its entire stake in its wholly owned step down subsidiary Black Ginger 461 Pty which......

Biocon, Mylan N.V. receive positive approval for Ogivri

Biocon and Mylan N.V. have been issued a positive opinion recommending approval of Ogivri, a biosimilar to Roche's Herceptin (trastuzumab) by the European Medicines Agency's Committee for Medicinal Products......

Top News

View all news

Reliance Power's arm wins arbitration award against NACC

Reliance Power's Wholly Owned Subsidiary -- Sasan Power has won an arbitration award against North American Coal Corporation (NACC). This is a major milestone in this arbitration with the award received......

Tata Steel's arm signs agreement to divest entire stake in Black Ginger 461

Tata Steel's wholly owned indirect subsidiary -- TS Global Minerals Holdings Pte has entered into an agreement to divest its entire stake in its wholly owned step down subsidiary Black Ginger 461 Pty which......

Biocon, Mylan N.V. receive positive approval for Ogivri

Biocon and Mylan N.V. have been issued a positive opinion recommending approval of Ogivri, a biosimilar to Roche's Herceptin (trastuzumab) by the European Medicines Agency's Committee for Medicinal Products......